Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea

Sogawa, R; Nakashima, C; Nakamura, T; Takeuchi, K; Kimura, S; Komiya, K; Narisawa, Y; Kimura, S; Sueoka-Aragane, N

Sogawa, R (corresponding author), Saga Univ Hosp, Dept Pharm, 5-1-1 Nabeshima, Saga 8498501, Japan.

IN VIVO, 2020; 34 (3): 1415

Abstract

Background/Aim: Afatinib, a 2nd generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) used in treatment of non-small cell l......

Full Text Link